The Caenorhabditis elegans (C. elegans) spermatheca, the site for embryo fertilization, is a tube composed of a single layer of cells that undergo cyclic stretching, constriction, and relaxation as ~150 oocytes pass through the gonad and into the spermatheca. The spermatheca consists of the distal neck, the bag, and the spermatheca-uterine (sp-ut) valve. Immediately after oocyte entry, the sp-ut valve constricts. After ~10 minutes, the bag begins to constrict, and the valve relaxes allowing the fertilized embryo to exit the spermatheca and enter the uterus. Upon oocyte entry, the phospholipase PLC-1 is activated and inositol trisphosphate (IP3) and diacylglycerol (DAG) are produced. IP3 signals the release of calcium from the ER, which, coupled with Rho signaling and myosin activation, ultimately results in cell contraction in the spermathecal bag. 3'-5'-Cyclic adenosine monophosphate (cAMP) is a fundamental secondary messenger responsible for signaling numerous diverse biological processes, including cell contractility and relaxation. Targets of cAMP include the cAMP-dependent protein kinase KIN-1/PKA. We have identified a signaling pathway that activates PKA as a regulator of spermathecal contractility. The pathway includes GSA-1 a G-protein alpha subunit of the Gs class, ACY-4 adenylyl cyclase, KIN-1/PKA and KIN-2 the regulatory subunit of PKA. Depletion of GSA-1 and KIN-1 during ovulation events results in the inability of embryos to exit the spermatheca. KIN-1 is necessary for the formation of contractile acto-myosin bundles, suggesting cAMP signaling affects actomyosin contractility. Using GCaMPv3, a genetically encoded calcium sensor, we observed that expressing GSA-1(GF) or treating animals with
kin-2 RNAi results in the initiation of calcium signaling in the spermatheca in the absence of oocyte entry, something we have never observed in WT animals. In summary, we present data that shows cAMP signaling plays a role in the spermatheca through PKA, can dramatically affect calcium signaling, and is able to alter actomyosin contractility.